meglumine antimoniate has been researched along with zithromax in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Layegh, P; Moghiman, T; Pezeshkpoor, F; Shakeri, MT; Vosugh, EM; Yazdanpanah, MJ | 1 |
| Abraham, D; Cajal, SP; Juarez, M; Krolewiecki, AJ; Matsumoto, T; Mimori, T; Romero, HD; Taranto, NJ | 1 |
| Dastgheib, L; Mirashe, Z; Naseri, M | 1 |
| Hashemzadeh, S; Khoddami, M; Layegh, P; Rajabi, O | 1 |
| Elias, VM; Osorio-Arango, K; Pinart, M; Pinzón-Flórez, CE; Reveiz, L; Romero, GA; Rueda, JR; Silveira Maia-Elkhoury, AN; Tweed, JA | 1 |
1 review(s) available for meglumine antimoniate and zithromax
| Article | Year |
|---|---|
Interventions for American cutaneous and mucocutaneous leishmaniasis.
Topics: Administration, Oral; Adult; Antiprotozoal Agents; Azithromycin; BCG Vaccine; Female; Humans; Hyperthermia, Induced; Immunocompetence; Injections, Intramuscular; Injections, Intravenous; Interferon-gamma; Leishmaniasis Vaccines; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Pentoxifylline; Phosphorylcholine; Randomized Controlled Trials as Topic | 2020 |
4 trial(s) available for meglumine antimoniate and zithromax
| Article | Year |
|---|---|
Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
Topics: Administration, Oral; Adult; Antiprotozoal Agents; Azithromycin; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2007 |
A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
Topics: Administration, Oral; Adult; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Argentina; Azithromycin; Endemic Diseases; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2007 |
Both combined oral azithromycin plus allopurinol and intramuscular Glucantime yield low efficacy in the treatment of Old World cutaneous leishmaniasis: a randomized controlled clinical trial.
Topics: Administration, Oral; Adult; Allopurinol; Anti-Bacterial Agents; Antimetabolites; Antiprotozoal Agents; Azithromycin; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome | 2012 |
Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.
Topics: Acute Disease; Administration, Cutaneous; Adolescent; Adult; Antiprotozoal Agents; Azithromycin; Child; Drug Administration Schedule; Female; Humans; Injections, Intralesional; Iran; Leishmaniasis, Cutaneous; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Time Factors; Treatment Outcome; Young Adult | 2016 |